Principal Financial Group Inc. reduced its position in Oxford Industries, Inc. (NYSE:OXM – Free Report) by 13.0% in the third quarter, Holdings Channel.com reports. The firm owned 69,713 shares of the ...

MML Investors Services LLC trimmed its position in shares of Oxford Industries, Inc. (NYSE:OXM – Free Report) by 14.6% in the third quarter, HoldingsChannel reports. The firm owned 2,453 shares of the ...

The deal will open the door for the company to tap into an archive of more than 2,000 designs by Key West Hand Print Fabrics ...

The increase in gross margin was primarily due to a $4 million lower LIFO accounting charge and lower discounts at Lilly Pulitzer. This was partially offset due to full-price retail and e-commerce ...

NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Girl Scouts of the USA has received a $30 million grant from Lilly Endowment Inc. to help more girls across the country build confidence, understand their ...

The Michigan Interscholastic Swim Coaches Association announced its 2024 Girls Swim & Dive Dream Team in the immediate aftermath of last month’s state finals, with one swimmer, diver or relay ...

(Bloomberg) — Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by the blockbuster weight-loss drug Zepbound. The company ...

Eli Lilly sells one of the most sought-after types of drugs today: weight loss drugs. The company’s Zepbound and Mounjaro have brought in blockbuster revenue, and more growth could be on the ...

One of the most important questions about the competitive prospects of Lilly against Novo Nordisk in the market for anti-obesity medicines is, quite simply, which company makes the more effective ...

Dec 11 (Reuters) - Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's (LLY.N), opens new tab weight-loss drug Zepbound to patients with obesity, becoming the ...

Eli Lilly's robust product portfolio, strategic acquisitions, and innovation-led initiatives drive its strong growth, positioning it well in the weight-loss, immunology, and oncology markets.